Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Altius Bioventures Capital is a venture capital firm founded to create and launch early-stage companies focused on advanced therapy technologies. Established in North Vancouver, Canada, the firm aims to transform the advanced therapy space, making treatments more affordable and accessible globally. Altius Bioventures operates primarily within North America, targeting the biotech and healthcare sectors.
The firm emphasizes strategic support alongside financial investment, which is crucial for the growth of early-stage companies. Altius Bioventures has developed a reputation for its commitment to enhancing the accessibility of advanced therapies, particularly in cell and gene therapy (CGT). The organization is structured to form Special Purpose Vehicles (SPVs) for targeted investments, allowing for tailored support to portfolio companies.
Altius Bioventures invests in early-stage companies that develop scalable tools and technologies in the advanced therapy sector, with a particular emphasis on cell and gene therapy (CGT). Their investment strategy includes forming Special Purpose Vehicles (SPVs) to facilitate targeted investments and strategic support. This approach allows Altius to align closely with founders from the outset, ensuring that both parties share a common vision for the company's growth.
The firm focuses on pre-seed, seed, and seed-plus stages, primarily within the biotech and healthcare sectors. Altius Bioventures seeks companies that demonstrate innovative solutions and scalable technologies that can significantly impact the advanced therapy landscape. Their commitment to early-stage investments positions them as a key player in the development of next-generation therapies.
Altius Bioventures has a diverse portfolio of companies within the biotech and healthcare sectors, focusing on advanced therapies. While specific company names are not disclosed in the provided data, the firm is known for investing in startups that are pioneering advancements in cell and gene therapy. Their portfolio reflects a commitment to supporting innovative solutions that enhance treatment accessibility and affordability.
Notable areas of investment include companies developing scalable tools and technologies that align with Altius's mission to transform the advanced therapy space. The firm’s strategic support model is designed to foster growth and innovation among its portfolio companies, ensuring they have the resources needed to succeed in a competitive market.
Emmanuel Grillot - Founding Partner, Managing Director. Emmanuel has extensive experience in investment and advanced therapies, leading multiple successful funding rounds.
Lee Buckler - Founding Partner, Sourcing Team. Lee specializes in identifying promising early-stage companies and has a strong background in biotech investments.
Troels Jordansen - Founding Partner, Investment Team. Troels brings expertise in investment strategy and portfolio management, focusing on biotech innovations.
Troels Jordansen - Founding Partner, Portfolio Team. Troels also plays a key role in managing relationships with portfolio companies, ensuring they receive the necessary support.
Shinichi Muto - Investment Committee, Strategic Advisor. Shinichi provides strategic insights based on his extensive experience in the biotech sector.
Chaminda Salgado - Investment Committee, Strategic Advisor. Chaminda offers expertise in investment strategies and market analysis.
Bryan Poltilove - Investment Committee, Strategic Advisor. Bryan has a strong background in venture capital and strategic investments.
Jason C. Foster - Investment Committee, Strategic Advisor. Jason contributes his knowledge of advanced therapies and market trends.
Arnaud Deladeriere - Strategic Advisor. Arnaud provides insights into the biotech landscape and supports the firm's investment strategies.
Startups interested in pitching to Altius Bioventures should use the contact form available on their website. It is important to include a comprehensive pitch deck that outlines the technology, market potential, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
As of October 2023, Altius Bioventures continues to focus on early-stage investments in the biotech and healthcare sectors, particularly in advanced therapies. The firm has been actively forming Special Purpose Vehicles (SPVs) to facilitate targeted investments in promising startups.
Recent activities include strategic partnerships with emerging companies in the cell and gene therapy space, aimed at enhancing treatment accessibility and affordability. Altius Bioventures remains committed to its mission of transforming the advanced therapy landscape through innovative investments.
What are Altius Bioventures' investment criteria?
Altius Bioventures focuses on early-stage companies in the biotech and healthcare sectors, particularly those developing scalable tools and technologies in advanced therapies, including cell and gene therapy.
How can startups apply or pitch to Altius Bioventures?
Startups can pitch to Altius Bioventures through their website at altiusbioventures.vc. It is recommended to include a detailed overview of the technology, market potential, and team background in the pitch deck.
What makes Altius Bioventures different from other venture capital firms?
Altius Bioventures emphasizes early commitment and alignment with founders, forming Special Purpose Vehicles (SPVs) for targeted investments, which allows for tailored support and strategic guidance.
What is the geographic scope of Altius Bioventures' investments?
The firm primarily invests in North America, focusing on companies that are positioned to make significant advancements in the biotech and healthcare sectors.
What is the typical check size for investments made by Altius Bioventures?
While specific check sizes are not disclosed, Altius Bioventures focuses on pre-seed, seed, and seed-plus stages, indicating a range that typically aligns with early-stage funding requirements.
What kind of post-investment involvement can founders expect from Altius Bioventures?
Altius Bioventures provides strategic support alongside financial investment, ensuring that portfolio companies receive guidance and resources necessary for growth and success in the advanced therapy sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.